Direct and selective labeling of α-amines or α-carboxylates of the N-terminal amino acid in proteins is a powerful approach for profiling proteins in complex mixtures. Approximately 80% of mammalian proteins are N-terminally acetylated. Thus, N-terminal labeling provides greater signal over background than does C-terminal labeling. However, such labeling must still be extremely selective for α-amines over lysine ε-amines, which are approximately 25 times more abundant in an average protein.
Investigators at UCSF have invented a general method to selectively label proteins on their N-termini with synthetic peptides. Briefly, this method uses an engineered enzyme subtiligase and a peptide substrate specially tailored to the proteomic workflow. The substrate comprises a peptide glycolate ester with a subtiligase cleavage site, a biotin label, and a TEV-cleavage site. The action of the subtiligase enzyme results in proteins that are selectively biotinylated on the N-terminus. The biotin label can then be used to capture these labeled proteins from a complex mixture using immobilized avidin. Finally, the TEV cleavage site allows for the enrichment of captured proteins or peptides for downstream analysis such as mass spectroscopy. Other N-terminal labels can also be used in place of biotin making the process very versatile.
Pre-clinical
Country | Type | Number | Dated | Case |
United States Of America | Issued Patent | 8,679,771 | 03/25/2014 | 2006-124 |
protein labeling, proteomics, N-termini labeling, protein profiling, synthetic peptides